YAP1 and breast cancer: Overall, our combined SNP array and PCR analyses suggest that 9qA1 (Yap1) amplification and 6qA2 (Met) amplification are the recurrent genomic lesions that may drive development of mammary tumours (with loss of luminal identity) from Trp53-null luminal MECs.